Global Human Microbiome Therapeutics Market Research Report 2023

Report ID: 1984712 | Published Date: Oct 2024 | No. of Page: 88 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 FMT
        1.2.3 Microbiome Drugs
    1.3 Market by Application
        1.3.1 Global Human Microbiome Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 C. difficile
        1.3.3 Crohn’s Disease
        1.3.4 Inflammatory Bowel Disease
        1.3.5 Diabetes
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Human Microbiome Therapeutics Market Perspective (2017-2028)
    2.2 Human Microbiome Therapeutics Growth Trends by Region
        2.2.1 Human Microbiome Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Human Microbiome Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Human Microbiome Therapeutics Market Dynamics
        2.3.1 Human Microbiome Therapeutics Industry Trends
        2.3.2 Human Microbiome Therapeutics Market Drivers
        2.3.3 Human Microbiome Therapeutics Market Challenges
        2.3.4 Human Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Human Microbiome Therapeutics Players by Revenue
        3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
    3.4 Global Human Microbiome Therapeutics Market Concentration Ratio
        3.4.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2021
    3.5 Human Microbiome Therapeutics Key Players Head office and Area Served
    3.6 Key Players Human Microbiome Therapeutics Product Solution and Service
    3.7 Date of Enter into Human Microbiome Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Therapeutics Breakdown Data by Type
    4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2023-2028)
5 Human Microbiome Therapeutics Breakdown Data by Application
    5.1 Global Human Microbiome Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Human Microbiome Therapeutics Market Size (2017-2028)
    6.2 North America Human Microbiome Therapeutics Market Size by Country (2017-2022)
    6.3 North America Human Microbiome Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Human Microbiome Therapeutics Market Size (2017-2028)
    7.2 Europe Human Microbiome Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Human Microbiome Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Human Microbiome Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Human Microbiome Therapeutics Market Size (2017-2028)
    9.2 Latin America Human Microbiome Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Human Microbiome Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Human Microbiome Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Enterome Bioscience
        11.1.1 Enterome Bioscience Company Detail
        11.1.2 Enterome Bioscience Business Overview
        11.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
        11.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.1.5 Enterome Bioscience Recent Development
    11.2 Rebiotix
        11.2.1 Rebiotix Company Detail
        11.2.2 Rebiotix Business Overview
        11.2.3 Rebiotix Human Microbiome Therapeutics Introduction
        11.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.2.5 Rebiotix Recent Development
    11.3 Seres Therapeutics
        11.3.1 Seres Therapeutics Company Detail
        11.3.2 Seres Therapeutics Business Overview
        11.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
        11.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.3.5 Seres Therapeutics Recent Development
    11.4 Vedanta Biosciences
        11.4.1 Vedanta Biosciences Company Detail
        11.4.2 Vedanta Biosciences Business Overview
        11.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
        11.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.4.5 Vedanta Biosciences Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Detail
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Detail
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
        11.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Takeda Pharmaceutical
        11.7.1 Takeda Pharmaceutical Company Detail
        11.7.2 Takeda Pharmaceutical Business Overview
        11.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
        11.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2017-2022)
        11.7.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of FMT
    Table 3. Key Players of Microbiome Drugs
    Table 4. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Human Microbiome Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Human Microbiome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Human Microbiome Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Human Microbiome Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Human Microbiome Therapeutics Market Share by Region (2023-2028)
    Table 10. Human Microbiome Therapeutics Market Trends
    Table 11. Human Microbiome Therapeutics Market Drivers
    Table 12. Human Microbiome Therapeutics Market Challenges
    Table 13. Human Microbiome Therapeutics Market Restraints
    Table 14. Global Human Microbiome Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Human Microbiome Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2021)
    Table 17. Ranking of Global Top Human Microbiome Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Human Microbiome Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Human Microbiome Therapeutics Product Solution and Service
    Table 21. Date of Enter into Human Microbiome Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Human Microbiome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Human Microbiome Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Human Microbiome Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Human Microbiome Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Human Microbiome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Human Microbiome Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Human Microbiome Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Human Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Human Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Human Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Human Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Human Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Human Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Enterome Bioscience Company Detail
    Table 42. Enterome Bioscience Business Overview
    Table 43. Enterome Bioscience Human Microbiome Therapeutics Product
    Table 44. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. Enterome Bioscience Recent Development
    Table 46. Rebiotix Company Detail
    Table 47. Rebiotix Business Overview
    Table 48. Rebiotix Human Microbiome Therapeutics Product
    Table 49. Rebiotix Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Rebiotix Recent Development
    Table 51. Seres Therapeutics Company Detail
    Table 52. Seres Therapeutics Business Overview
    Table 53. Seres Therapeutics Human Microbiome Therapeutics Product
    Table 54. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Seres Therapeutics Recent Development
    Table 56. Vedanta Biosciences Company Detail
    Table 57. Vedanta Biosciences Business Overview
    Table 58. Vedanta Biosciences Human Microbiome Therapeutics Product
    Table 59. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Vedanta Biosciences Recent Development
    Table 61. Bristol-Myers Squibb Company Detail
    Table 62. Bristol-Myers Squibb Business Overview
    Table 63. Bristol-Myers Squibb Human Microbiome Therapeutics Product
    Table 64. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Bristol-Myers Squibb Recent Development
    Table 66. Johnson & Johnson Company Detail
    Table 67. Johnson & Johnson Business Overview
    Table 68. Johnson & Johnson Human Microbiome Therapeutics Product
    Table 69. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Johnson & Johnson Recent Development
    Table 71. Takeda Pharmaceutical Company Detail
    Table 72. Takeda Pharmaceutical Business Overview
    Table 73. Takeda Pharmaceutical Human Microbiome Therapeutics Product
    Table 74. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Takeda Pharmaceutical Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Microbiome Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. FMT Features
    Figure 3. Microbiome Drugs Features
    Figure 4. Global Human Microbiome Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. C. difficile Case Studies
    Figure 6. Crohn’s Disease Case Studies
    Figure 7. Inflammatory Bowel Disease Case Studies
    Figure 8. Diabetes Case Studies
    Figure 9. Others Case Studies
    Figure 10. Human Microbiome Therapeutics Report Years Considered
    Figure 11. Global Human Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Human Microbiome Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Human Microbiome Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Human Microbiome Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2021
    Figure 17. North America Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Human Microbiome Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Human Microbiome Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Human Microbiome Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Human Microbiome Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Human Microbiome Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Human Microbiome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 46. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 47. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 48. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 51. Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
Frequently Asked Questions
Human Microbiome Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Microbiome Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Microbiome Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Humidity Sensor

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More